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Abstract
Background:  Avian influenza viruses of the H7 subtype have caused multiple outbreaks in
domestic poultry and represent a significant threat to public health due to their propensity to
occasionally transmit directly from birds to humans. In order to better understand the cross
species transmission potential of H7 viruses in nature, we performed biological and molecular
characterizations of an H7N3 virus isolated from mallards in Canada in 2001.
Results: Sequence analysis that the HA gene of the mallard H7N3 virus shares 97% identity with
the highly pathogenic avian influenza (HPAI) H7N3 virus isolated from a human case in British
Columbia, Canada in 2004. The mallard H7N3 virus was able to replicate in quail and chickens, and
transmitted efficiently in quail but not in chickens. Interestingly, although this virus showed
preferential binding to analogs of avian-like receptors with sialic acid (SA) linked to galactose in an
α2–3 linkage (SAα2–3Gal), it replicated to high titers in cultures of primary human airway epithelial
(HAE) cells, comparable to an avian H9N2 influenza virus with human-like α2–6 linkage receptors
(SAα2–6Gal). In addition, the virus replicated in mice and ferrets without prior adaptation and was
able to transmit partially among ferrets.
Conclusion: Our findings highlight the importance and need for systematic in vitro and in vivo
analysis of avian influenza viruses isolated from the natural reservoir in order to define their
zoonotic potential.
Background
Influenza A viruses are classified based on the antigenic
properties of the surface proteins hemagglutinin (HA)
and neuraminidase (NA). To date, 16 HA and 9 NA sub-
types have been described. Wild aquatic birds (Orders
Anseriformes and Charadriiformes) are considered the
major reservoir of influenza A viruses in nature [1]. In
these birds, influenza viruses usually replicate in the intes-
tinal tract, cause no disease, and spread by fecal contami-
nation of water. These viruses occasionally infect
terrestrial domestic birds (order Galliformes) and in a
limited number of mammalian species including humans
[2-5]. On rare occasions, these infections initiate horizon-
tal chains of transmission and establishment of new host-
adapted virus lineages.
Avian influenza viruses with the H7 HA (herein H7
viruses) have been associated with numerous outbreaks in
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poultry worldwide with devastating effects on the industry
due to mass mortality, depopulation and trade restrictions
[6]. Prior to 2003, infection with H7 viruses was not con-
sidered a serious health threat, although some H7 out-
breaks in poultry or seals were sporadically associated
with conjunctivitis by occupational exposure [7-9]. How-
ever, the H7N7 outbreak in the Netherlands in 2003
prompted a re-evaluation of the human health risks
attributed to these viruses. The H7N7 virus infected at
least 89 people with one case of fatal pneumonia.
Although mild conjunctivitis was the most common pres-
entation, mild influenza-like symptoms with respiratory
involvement were also reported. Infections with H7
viruses may be more common than we currently recog-
nize. Indeed, seroepidemiological studies revealed proba-
ble avian-to-human transmission of low pathogenic avian
influenza (LPAI) H7 viruses in Italy [10]. In North Amer-
ica, avian H7 viruses have also been associated with
human infections. Early in 2004, outbreaks of LPAI and
HPAI H7N3 occurred among poultry in British Columbia,
Canada [11]. Two poultry workers developed mild unilat-
eral conjunctivitis, accompanied by coryza and headache.
LPAI H7N3 was isolated from the respiratory secretions of
one worker, whereas the HPAI H7N3 virus was isolated
from conjunctival specimens from a second worker
[12,13]. An isolated case of LPAI H7N2 virus infection
was identified in an adult male from the New York metro-
politan area, in November 2003, but the source of infec-
tion was not identified [14]. Thus, direct transmission of
both HPAI and LPAI of the H7 subtype to humans high-
light the need for a detailed molecular and biological
characterization of H7 viruses in vitro and in vivo in order
to better assess their zoonotic potential.
Recent studies show that some HPAI and LPAI H7 sub-
types isolated from domestic poultry can infect mice and/
or cause disease in ferrets without previous adaptation
[15-17]. However little is known about the potential of
H7 viruses isolated from wild aquatic birds to infect mam-
mals. Understanding the potential of avian influenza
viruses from the natural reservoir to infect various other
animal species is crucial to determine their host range and
zoonotic potential. Recently, Belser et al. [18] provided
evidence that some contemporary Eurasian and North
American influenza H7 viruses replicated efficiently in the
upper respiratory tract of ferrets and were capable of direct
contact transmission in this species.
In this study, we performed in vitro and in vivo characteri-
zations of a A/mallard/Albetera/24/01 (H7N3) virus iso-
lated in Alberta, Canada, 2001 (herein Mal/01). We found
that the Mal/01 virus possesses characteristics of a typical
avian influenza virus in vitro, i.e. it binds strongly to α2–3
avian-like receptors, and infects almost exclusively ciliated
cells in air-liquid interface cultures of human airway epi-
thelial cells. The Mal/01 virus transmitted to direct contact
ferrets, although no airborne respiratory droplet transmis-
sion was observed. Our studies suggest that changes in
receptor specificity, might not be necessarily required for
some H7 viruses to infect and/or transmit in mammals.
These studies highlight the importance of carefully scruti-
nizing the characteristics of viruses from the wild bird res-
ervoir on a systematic basis in order to ascertain their
zoonotic and pandemic potential.
Results and discussion
Sequence analysis of Mal/01 reveals close relationship to 
poultry H7 viruses that infected humans in British 
Columbia, Canada
The molecular features conducive to interspecies trans-
mission of influenza viruses are largely unknown. We
were interested in determining the biological and molec-
ular characteristics as well as the host range of a typical
mallard H7N3 virus that was circulating in wild ducks in
Canada in 2001. This virus circulated in ducks in Canada
prior to the H7 outbreak in poultry that transmitted to
humans in 2004. Genome sequence analysis revealed that
Mal/01 virus shares between 97.5% to 100% amino acid
identity with the HPAI A/Canada/rv504/2004 (H7N3)
virus with the exception of the NS gene (Table 1). While
the NS gene of A/Canada/rv504/2004(H7N3) belongs to
allele A, the Mal/01 H7N3 virus contains an NS gene that
belongs to allele B. Mal/01 virus also shares more than
99.8% nucleotide sequence identity and more than
99.9% amino acid identity with another virus sequence
deposited in Genbank, A/mallard/Alberta/34/2001
(H7N1) (Table 2). The N3 NA segment of Mal/01 is
closely related to an H2N3 avian influenza virus, isolated
from mallards in Canada in 2003 (Table 2). It must be
noted that Mal/01 is a LPAI virus and in that regard is phe-
notypically different from the HPAI A/Canada/rv504/
2004 (H7N3) virus. In addition to the different cleavage
site, the HA of Mal/01 virus differs from the human isolate
at three other positions as shown in Table 1. Taken
together, these observations suggest that a potential pre-
cursor of the H7N3 virus that caused the outbreak in Can-
ada was present in the wild duck population at least 3
years before the outbreak.
In vitro characterization of RGMal/01 shows efficient 
replication in human airway epithelial cells despite strong 
α2–3 receptor specificity
We have previously shown that Mal/01 virus displayed
exclusive preference for SAα2–3Gal-resialylated chicken
red blood cells (CRBCs), whereas a prototypic human
H3N2 virus (Pan/99) and an avian H9N2 virus
(RGWF10) with human-like receptor specificity bound
exclusively to SAα2–6Gal-resialylated CRBCs [19]. In this
study, we further analyzed its receptor glycan preference
using glycan microarray technology to survey more thanVirology Journal 2009, 6:126 http://www.virologyj.com/content/6/1/126
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100 sialoglycans simultaneously [20]. Using reverse
genetics we rescued the Mal/01 virus (RGMal/01) and
generated a homogeneous population of virus corre-
sponding to the most prevalent virus population in the
original isolate. Analysis of the RGMal/01 virus with a
microarray of sialoglycans revealed strong binding to
multiple sialoside structures with α2–3 linkage to galac-
tose(Fig 1A). Only minimal binding to a few α2–6 sialo-
sides was detected (Fig 1A). These data demonstrated that
the RGMal/01 virus is a typical avian influenza virus with
nearly exclusive α2–3 sialoside receptor specificity.
Differentiated human airway epithelial (HAE) cell culture
is a well-characterized in vitro model of human respiratory
tract epithelium. The apical surface of HAE cells cultured
at the air-liquid interface contains both ciliated cells and
mucus-secreting non-ciliated cells. These cultures express
SAα2–3Gal receptors predominantly on ciliated cells,
while SAα2–6Gal receptors are presented mainly on non-
ciliated cells [19,21-23]. Replication of influenza viruses
in this in vitro model has defined a distinctive cell tropism
pattern between avian and human influenza viruses based
on their receptor preferences. While avian influenza
viruses infect predominantly ciliated (SAα2–3Gal recep-
tor) cells, human viruses replicate preferentially in non-
ciliated cells (SAα2–6Gal receptors). Interestingly, avian
influenza viruses that have acquired SAα2–6Gal receptor
specificity show a human-like virus cell tropism by infect-
ing mostly non-ciliated cells [19]. In addition, avian and
human viruses that replicate in non-ciliated cells tend to
produce more virus progeny compared to those that infect
ciliated cells. Based on its preference binding to α2–3 sia-
losides and the origin of the Mal/01 virus, it was not unex-
pected to observe that it infected preferentially ciliated
cells in HAE cultures within single round replication (Fig
1B). Thus, there was good agreement between the Mal/01
virus receptor specificity and its cell tropism in HAE cul-
tures. We further examined the replication kinetics of
RGMal/01 in HAE cultures. As controls, we included Pan/
99 and RGWF10 which exhibit human-like receptor spe-
cificity and replicate preferentially in non-ciliated cells
[19]. HAE cultures were inoculated on the apical side at a
MOI of 0.2. Progeny viruses released into the apical were
harvested and titrated in MDCK cells (Fig. 1C) whereas
cell monolayers were fixed and stained to reveal cell type
(cilia) and presence of viral antigen (Fig. 1D). The RGMal/
01-infected HAE cells released ~100 times less virus than
the human Pan/99 virus, but reached levels comparable to
the avian RGWF10 H9N2 virus, which has human-like
receptor binding specificity (Fig. 1C). The relatively effi-
cient replication of the RGMal/01 virus in HAE cultures is
supported by ciliated cells as indicated by the detection of
viral antigen in these cells rather than in non-ciliated cells,
even at 60 hpi (Fig. 1D). Our in vitro model results suggest
Table 1: Sequence comparison of Mal/01 versus A/Canada/rv504/2004(H7N3).
Virus gene segments
(Gene accession NO.)
Identity, nt Identity, aa No. of substitution (aa)
PB2 (DQ017509.1) 94.7% 99.3% 5
PB1 (DQ017507.1) 97.7% 99.5% 4
PA (DQ017508.1) 98.7% 99.5% 3
HA (DQ017504.1) 97.0% 98.9% 3a
NP (DQ017514.1) 93.0% 98.8% 6
NA (DQ017503.1) 96.3% 97.5% 11
M (DQ017516.1) 97.5% 100%b 0b
NS (DQ017506.1) 67.4% 68.3%c 74c
a Polybasic cleavage site in HA0 protein was excluded.
b M1 protein
c NS1 protein
Table 2: Influenza A viruses with greatest nucleotide and amino acid sequence identity to Mal/01 as determined by a BLAST search of 
the influenza virus database.
Virus gene segments Identity, nt Identity, aa Virus designation
PB2 99.8% 99.9% A/mallard/Alberta/34/2001(H7N1)
PB1 100% 100% A/mallard/Alberta/34/2001(H7N1)
PA 99.9% 100% A/mallard/Alberta/34/2001(H7N1)
HA 100% 100% A/mallard/Alberta/34/2001(H7N1)
NP 99.8% 100% A/mallard/Alberta/34/2001(H7N1)
NA 97.9% 99.1% A/mallard/Alberta/79/2003(H2N3)
M1 0 0 % 1 0 0 % a A/mallard/Alberta/34/2001(H7N1)
NS 100% 100%b A/mallard/Alberta/34/2001(H7N1)
aM1 protein identity
bNS1 protein identityVirology Journal 2009, 6:126 http://www.virologyj.com/content/6/1/126
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that although the virus has high affinity for the avian-like
α2–3-linked SA receptors, it may have the potential to
replicate efficiently in epithelial cells of the human respi-
ratory tract. Therefore, we analyzed the replication of
RGMal/01 in avian and mammalian in vivo models.
Replication and transmission of RGMal/01 in domestic 
land-based birds
To determine whether RGMal/01 could readily replicate
and transmit in domestic poultry, three quail or chickens
were infected with 5 × 106EID50 of the RGMal/01. At 24
hpi, one additional uninfected bird was introduced into
each of the cages housing the infected quail or chickens.
The RGMal/01 virus established a respiratory infection in
quail without overt signs of disease. Transmission to
direct contact quail occurred readily at 3 dpi consistent
with previous observations [24] (Table 3). These results
are highly significant considering the fact that H7 viruses
have been frequently found in live bird markets in the
United States in which quail are a common item [25]. In
contrast, the RGMal/01 virus replicated less efficiently in
white leghorn chickens and was not transmit to direct
Receptor specificity of RGMal/01 and single and multi round replication of the virus in HAE cells Figure 1
Receptor specificity of RGMal/01 and single and multi round replication of the virus in HAE cells. (A) Receptor 
specificity was measured by Glycan Array. Virus was analyzed at hemagglutination titers of 128 per 50 μl. The virus exhibited a 
strong preference for binding to mainly avian-type α 2–3 receptors, but not α 2–6 sialosides. 1–32 represent the glycans that 
contain α 2–3 SA (light gray), whereas 33–45 are the glycans with α 2–6 SA (dark gray). (B) HAE cultures were infected with 
RGMal/01 at an MOI of 1.0 and fixed at 7 hpi. The cilia (gray) and viral antigen (red) were visualized by double immunostaining. 
RGMal/01 is more efficient at infecting ciliated cells. (C) HAE cultures were inoculated via the apical side with the viruses at an 
MOI of 0.2. The progeny viruses released into the apical side were collected at the indicated time points and titrated in the 
MDCK cells by performing a TCID50 assay. Each bar represents the average for two independent experiments run with dupli-
cate HAE cultures. (D) At end of the sampling (60 hpi) described from panel C, the cultures were fixed and stained for cilia 
(gray) and distribution of viral antigen (red).
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contact chickens. RGMal/01 virus was absent in the lungs
of inoculated or contact chickens at 3 dpi, whereas virus
was readily detected in quail (data not shown), consistent
with the replication and transmission studies.
Replication of the RGMal/01 virus in mice
In order to determine the ability of the RGMal/01 virus to
replicate in mammals, we inoculated mice by the i.n.
route with 5.0 × 101 to 5 × 105TCID50 of the RGMal/01 (3
mice/dose). Mice infected with 500 TCID50 or more had
reached 4 to 6 log10TCID50/lung with escalating virus
doses (Table 4). No virus was detected in the brain of mice
regardless of the inoculation dose used (data not shown).
In an independent study, 4 mice infected with 5 × 105
TCID50 of the RGMal/01 were monitored and weighed
daily for 14 days in order to determine the clinical
response to infection. Slight body weight loss was
recorded between days 2 and 3 pi, but mice showed no
clinical signs of disease throughout the observation
period (Fig. 2A). Taken together, these studies indicate
that the RGMal/01 virus can replicate in mice without pre-
vious adaptation. They also underscore the need to better
understand the ability of these viruses to infect mammals
sub clinically and generate strains with potentially novel
features.
Replication and transmission of the RGMal/01 virus in 
ferrets
We used the ferret model to further characterize the repli-
cation and transmission of RGMal/01 in mammals. Three
ferrets housed in separate cages were inoculated i.n. with
5 × 105 TCID50 of the RGMal/01 virus. At 24 hpi, one
naïve ferret was introduced into the same cage in direct
contact with the infected ferret. In addition, respiratory
droplet contact ferrets were included as previously
described [26]. Signs of disease, changes in body temper-
ature and body weight, as well as virus shedding were
monitored daily. No signs of overt disease, such as leth-
argy, anorexia, sneezing and cough, were observed in any
of the inoculated animals. Transient elevation of body
temperature (1.1–1.6°C) was detected in the 3 infected
ferrets at day 2 pi (Table 5). Maximum body weight loss
in the infected ferrets was less than 4%. Virus was detected
in all the inoculated ferrets, as demonstrated by the detec-
tion of virus in nasal washes using Flu DETECT™ Antigen
Capture Test Strip (not shown), and viral titration, with
peak titers ranging from 104.7 to 106.2 TCID50/ml (Fig 2B).
All of the infected ferrets cleared the viruses by 7 dpi. The
virus transmitted to two out of three direct contact ferrets
at 3 or 4 dpi, and peak titers reached between 105.4 to 106.4
TCID50/ml, respectively. The contact ferret that shed great-
est virus quantities (106.4 TCID50/ml) shared the cage with
the inoculated ferret that also shed the highest peak virus
titers (106.2 TCID50/ml). Anti-Mal/01 HI antibodies were
detected in all three inoculated ferrets as well as in the two
direct contact ferrets that shed virus, but not in the contact
ferret that did not shed virus in nasal secretions (Table 5).
Therefore our data indicate that the RGMal/01 virus repli-
cated efficiently in ferrets and was transmissible to direct
contact ferrets. None of the three respiratory droplet con-
tacts were positive for virus isolation or seroconversion
(data not shown), indicating that the RGMal/01 was not
able to transmit via aerosolized respiratory droplets. This
finding is consistent with the lack of efficient transmission
of this virus subtype among humans.
To evaluate the virus replication kinetics and tissue tro-
pism in the inoculated ferrets, we infected 3 ferrets i.n.
with 5 × 105 TCID50of the RGMal/01 and collected sam-
ples from different tissues at 8, 24 and 68 hpi. As shown
in Fig 3A, high levels of virus replication were detected in
upper (nasal turbinate and trachea) and lower respiratory
tract (lung). The virus showed peak titers of 106.2 TCID50
in nasal turbinate and trachea 105.2 TCID50 at 24 hpi, then
declined by 68 hpi, whereas virus titers in lungs were
maintained at a similar level at all 3 time points. The virus
did not spread to the brain but it was detected in the olfac-
tory bulbs. No virus was isolated from the spleen, kidney,
heart, liver and intestine at any of the time points. Histo-
logical examination of the lung of inoculated ferrets
revealed moderate interstitial pneumonia and evident
infiltration of inflammatory cells, including mononuclear
Table 3: Replication and transmission study of RGMal/01 in chickens and quaila.
Groups Number with positive tracheal swab/total N
(Log10EID50/ml ± SD)
Day 1 Day 3 Day 5 Day 7 Day 9 Day 11
Inoculated quailb 3/3 3/3 3/3 (4.6 ± 0.6) 3/3 3/3 0/3
Contact quailb 0/3 3/3 3/3 3/3 3/3 1/3
Inoculated chickenb 3/3 2/3 (2.7 ± 0) 0/3 0/3 0/3 0/3
Contact chickenb 0/3 0/3 0/3 0/3 0/3 0/3
a Groups of three birds were inoculated orally, intraocularly, intranasally, and intratracheally with 5 × 106 EID50 of RGMal/01/ml. A volume of 0.6 ml 
or 1.0 ml of virus inoculum was used for quail and chickens, respectively. The next day after infection, three naïve birds were introduced into the 
same cage as the infected birds. Tracheal and cloacal swab samples were collected from the chickens every 2 days for 11 days after inoculation
b Cloacal swabs are negative for virus isolation.Virology Journal 2009, 6:126 http://www.virologyj.com/content/6/1/126
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Replication of the RG Mal/01 in mice and ferrets Figure 2
Replication of the RG Mal/01 in mice and ferrets. (A) Four five-week-old BALB/c mice were infected under isoflurane 
anesthesia with 5 × 105TCID50/50 μl of RGMal/01. Body weight was measured for 14 days after infection. Body weight was 
compared with the body weight on day "0" before infection. (B) Three ferrets were inoculated i.n. with 5 × 105TCID50 of 
RGMal/01. Twenty-four hours later, one naïve ferret was added to the same cage as each of the infected ferrets. Viral titers 
were measured in nasal washes collected daily and were titrated in MDCK cells. The titers are expressed as log10 numbers of 
TCID50/ml. The detection limit is 0.699 log10TCID50/ml.
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cells, lymphocytes and neutrophils, noticeable by 24 hpi
and becoming more severe by 68 hpi (Fig. 3B). No evident
lesions were observed in tracheas from the inoculated fer-
rets at any time point during infection (data not shown).
Conclusion
Avian influenza viruses of H7 subtypes are frequently iso-
lated from domestic poultry and have recently become of
a significant public health concern due to their propensity
to transmit directly from infected poultry to humans. Pre-
vious studies with HPAI H7 and LPAI H7 isolated from
domestic land-based birds have shown that these viruses
can replicate in mice and ferrets without adaptation [16-
18,27]. Aquatic birds are the natural reservoir for influ-
enza A viruses, however little is known about the potential
of viruses from this primordial reservoir to infect mam-
mals. In this report we performed biological and molecu-
lar characterizations of a H7N3 virus isolated from a
mallard in Canada, 2001. Our results indicated that 7 of
the gene segments of the Mal/01 share high level of simi-
larity with influenza A/Canada/rv504/2004 (H7N3), the
HPAI virus isolated from a human conjunctivitis case in
Canada in 2004. Interestingly, the RGMal/01 virus repli-
cated well in HAE cells despite its strict SAα2–3Gal recep-
tor-binding specificity. Consistent with this observation,
the virus was able to infect mice and replicate and trans-
mit in ferrets without causing substantial morbidity and
with no mortality.
An outbreak of avian influenza in 2004 in British Colum-
bia, Canada, included LPAI and HPAI viruses of the H7N3
subtype. Our genomic sequence analysis of Mal/01 indi-
cated that with the exception of NS, all other genes
encoded proteins that share more than 97% amino acid
sequence similarity with influenza A/Canada/rv504/2004
(H7N3) from a human case linked to the poultry out-
break. Thus, it is tempting to speculate that a virus with
the potential to infect mammals was circulating in wild
birds in Canada as early as in 2001. The H7N3 mallard
virus did not replicate particularly well in chickens. How-
ever, it was able to replicate and transmit readily in Japa-
nese quail, a common item in live bird markets in which
H7 viruses have been frequently found [28-30].
RGMal/01 replicated to high titers in the respiratory tracts
of mice and ferrets. However, efficient replication of a
LPAI in the mammalian respiratory tract is not completely
unprecedented. In an earlier study, we found that the HA
of recent H9N2 viruses (including RGWF10) that contain
leucine (L) at position 226 of the HA receptor-binding site
(H3 numbering) bind efficiently to α2–6-linked SA moi-
eties. The virus with L226 replicated more efficiently in
ferrets than the virus with glutamine at this position and
it was able to transmit to contact ferrets [19,31]. Interest-
ingly, in the present study we observed that the RGMal/01
virus, which has typical avian receptor binding preference
for  α2–3-linked SA, was present in nasal secretions at
higher concentrations than another avian virus, WF10.
Nevertheless, RGMal/01 was shed at lower concentrations
than a prototype H3N2 human influenza virus, Mem/98
[31]. High levels of RGMal/01 virus shedding were
detected from both the upper and the lower respiratory
tract of ferrets. Similarly, Belser et al. observed that, with-
out causing substantial morbidity or mortality, some
North American H7 viruses, isolated from humans or
poultry, replicated efficiently in the respiratory tract of
Table 4: Infectivity of the RGMal/01 virus in micea
Virus infection dose (TCID50) No. with positive titer in lung/total no.
(Log10TCID50/lung ± SD)
5 × 105 3/3 (5.6 ± 0.4)
5 × 104 3/3 (5.2 ± 0.3)
5 × 103 3/3 (4.5 ± 0.4)
500 3/3 (3.7 ± 0.6)
50 0/3
a 4–5 week old female BALB/c mice were anesthetized by isoflurane and infected i.n. with the RGMal/01 virus at a dose 50, 500, 5.0 × 103, 5.0 × 104, 
5 × 105 TCID50/50 μl. At day 3 post-inoculation, lungs from three infected mice were collected and homogenized to titrate the virus by TCID50 
assay in MDCK cells.
Table 5: Clinical signs and seroconversion in ferrets infected with RGMal/01.
Animals Virus detected in nasal 
washa
Max body temperature 
rise (°C)
Max body weight loss 
(%)
Lethargy
(Day of onset)
Sneezing
(Day of onset)
Serum
(HI titer)b
Inoculated 3/3 1.1,1.1,1.6 3.9, 3.8, 2.8 0/3 0/3 80, 80,160
Direct Contact 2/3 0.9, 0, 1.7 0, 1.0, 9.3 0/3 0/3 <10, 80,160
a Virus in nasal washes was analyzed using Flu DETECT ™ Antigen Capture test Strip (Synbiotics Corp.) and titrated by TCID50 assay in MDCK cells
bBlood was collected at 14 dpi, RGMal/01 was used in the HI assay to detect anti-H7 antibodies.Virology Journal 2009, 6:126 http://www.virologyj.com/content/6/1/126
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Replication kinetics and histopathology of the RGMal/01 in inoculated ferrets Figure 3
Replication kinetics and histopathology of the RGMal/01 in inoculated ferrets. Three ferrets were inoculated i.n. 
with 5 × 105TCID50 of RGMal/01 virus. At 8, 24, and 68 hpi, each ferret was euthanized. (A) Brain, olfactory bulb (OB), nasal 
turbinate (NT), trachea, lung, kidney, liver, spleen and intestine were harvested, weighted and homogenized in PBS. Virus in 
these tissues was titrated in MDCK cells. The titers are expressed as log10 numbers of TCID50 per ml of 10% (w/v) tissue 
homogenate. The detection limit is 0.699 log10TCID50/ml. (B) Lung was collected and fixed with formalin. The lung of a mock-
infected ferret was collected as negative control. Sections of 5 μm thick were cut and routinely processed for H&E staining. 
Note that the severe inflammatory infiltration is progressing in the infected lung.
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both mice and ferrets [18]. Virus titers measured in the
respiratory tract of the ferrets were even higher than those
observed following infection with human H3N2 viruses
[18]. In addition, high titers of virus (ranging from 106.3
to 107.8 EID50/ml) were recovered in nasal washes from
ferrets inoculated with some of the H5N1 viruses having
high binding affinity to SAα2–3Gal receptor [32]. There-
fore, our data are consistent with other findings and sug-
gest that LPAI avian influenza viruses do not require high
binding affinity to human-like receptors in order to repli-
cate efficiently in the upper respiratory tract of ferrets.
More importantly, our results are consistent with the
notion high levels of nasal shedding are necessary but not
sufficient to achieve efficient contact (or droplet) trans-
mission of influenza viruses in ferrets.
Although the mallard H7N3 virus has nearly exclusive
SAα2–3Gal receptor binding specificity and replicates pre-
dominantly in ciliated HAE cells, it reaches titers similar
to another avian virus with human-like receptor binding
specificity which replicates in non-ciliated cells. Consider-
ing that the RGMal/01 virus antigen co-localized only
with ciliated cells after multiple replication cycles in HAE
cells, it is unlikely that other cell types served as substrate
for virus multiplication. The efficient replication in the
SAα2–3Gal receptor-containing cells might provide a pos-
sible explanation for efficient replication of the RGMal/01
in the upper respiratory tract of ferrets: the virus is pre-
dicted to replicate efficiently in ciliated airway epithelial
cells populations. Similarly, productive H5N1 viral repli-
cation can still be detected in ex vivo cultures of human
nasopharyngeal, adenoid, and tonsillar tissue when
infected with high MOI of 5.0 [33].
To our knowledge, this is the first report showing that an
avian influenza H7 virus isolated from aquatic birds rep-
licates in and is transmitted to ferrets by direct contact
without prior adaptation by serial passage. Our results in
HAE and ferret models are consistent with the limited
human-to-human transmission following humans' infec-
tions with H7 viruses with typical avian-like characteris-
tics [34]. Belser et al previously reported similar findings
with H7N2 viruses isolated from poultry. However, find-
ings with H7 viruses contrast transmission studies of
H5N1 viruses in ferrets [32,35]. Although partial trans-
mission of recent H5N1 strains to contact ferrets was
detected by seroconversion, usually little or no virus was
present in the nasal washes of contact ferrets [32,35].
Additional functional changes would seem to be required
to enable the RGMal/01 virus for sustained aerosolized
respiratory droplet transmission, which might include,
among other features, switching to α2–6-sialoglycan
binding preference. A recent study indicated that affinity
for human-like α2–6-linked SA receptors may not be suf-
ficient to allow efficient transmission of H5N1 virus
among ferrets [35], suggesting that additional structural
features of the receptor or other yet unidentified viral
functions are critical as well. For example, the topology of
long chain α2–6-sialylated glycan receptors on the human
upper respiratory tissues may play such role [36]. An
avian/human H9N2 reassortant virus, which already dis-
played human-like receptor specificity, required adapta-
tion by serial passage in ferrets in order to obtain a strain
that was transmitted by respiratory droplets [26]. It
remains to be elucidated whether a similar approach
would lead to respiratory droplet transmission of a H7
subtype virus. Consequently, it is also essential that avian
surveillance programs contemplate the analysis of recep-
tor specificity of strains isolated from the field in the con-
text of other in vitro and  in vivo approaches to clearly
delineate their zoonotic potential.
At the time of writing this report, an influenza pandemic
was declared, caused by subtype H1N1 triple reassortant
virus of swine origin containing genes derived from
human, avian and swine influenza viruses. Noteworthy is
the fact that this new reassortant lacks most of the features
that scientists have come to recognize as virulence mark-
ers of influenza viruses in humans. It does not encode the
virulence marker PB1F2, the NS1 is 219 amino acids long
and thus lacks the PDZ domain, PB2 does not encode
lysine 627, among other features. In this regard, it is
important to note that the NS gene of Mal/01 belongs to
allele B, which to our knowledge has not been associated
with infections in mammals. However, this gene does not
appear to have been an impediment for the replication of
the RGMal/01 virus in mice or for the efficient replication
and partial transmission in ferrets. Thus, further studies
are needed in order to better identify and characterize viral
determinants of virulence and transmission of avian influ-
enza viruses in mammals.
Materials and methods
Viruses and cells
The A/Mallard/Alberta/24/01 (H7N3) (Mal/01), A/
Guinea fowl/Hong Kong/WF10/99 (H9N2) (WF10) and
A/Panama/2007/99 (H3N2) (Pan/99) viruses were
obtained from the influenza repository at St. Jude Chil-
dren's Research Hospital, Memphis, TN. Avian viruses
were propagated in 10-day-old embryonated, specific-
pathogen-free (SPF) chicken eggs, while the human influ-
enza virus was propagated in Madin-Darby canine kidney
(MDCK) cells. Virus stocks were maintained at -80°C
until use. MDCK cells were maintained in modified
Eagle's medium (MEM) (Sigma-Aldrich, St. Louis, MO)
containing 5% fetal bovine serum (Sigma-Aldrich, St.
Louis, MO). 293-T human embryonic kidney (HEK) cells
were cultured in OptiMEM I (GIBCO, Grand Island, NY)
containing 5% FBS. Passage 1 human airway epithelial
cells (HAE) were purchased from Cell Applications, Inc.
(San Diego, CA). The cells were expanded and differenti-Virology Journal 2009, 6:126 http://www.virologyj.com/content/6/1/126
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ated as described previously [19]. The median tissue cul-
ture infectious dose (TCID50) of each virus was
determined using MDCK cells. Avian influenza viruses
were also titrated by the Reed and Muench [37] method to
determine the 50% egg infectious dose (EID50).
Viral gene cloning and sequencing
Total viral RNA was extracted from infected allantoic fluid
using the RNeasy kit (Qiagen, Valencia, CA, USA) in
accordance with manufacturer's instructions. Reverse
transcription was carried out with the uni12 primer (5'-
AGCAAAAGCAAGG-3') and AMV reverse transcriptase
(Promega, Madison, WI, USA) [38]. PCR amplification
was performed using universal primers described by Hoff-
mann et al [38] as well as specific primers (primer
sequences available upon request). PCR products were
sequenced using the BigDye-Terminator protocol V3.1
(Applied Biosystems, Foster City, CA). For the generation
of H7N3 virus by reverse genetics, PCR products corre-
sponding to each of the 8 genes were purified and cloned
into the vector pDP2002. Plasmid sequences were com-
pared to the sequences generated from the wild type virus
(obtained by direct sequencing of the RT-PCR products).
Only clones that exactly matched the parental virus
sequence were used for virus rescue by reverse genetics.
Reverse genetic Mal/01 (RGMal/01) was rescued accord-
ing to the protocol described previously [39]. The nucle-
otide sequences determined in this study are available
from GenBank (Table 1). The reverse genetics-generated
WF10 (RGWF10) virus has been previously described
[29].
Sialoglycan microarray analysis of whole virions
RGMal/01 virus was propagated in 10-day-old embryo-
nated chicken eggs as described previously [19]. Virus
infectivity was inactivated by 0.02% β-propiolactone
treatment (Sigma-Aldrich, St. Louis, MO). Allantoic fluid
containing inactivated virus was clarified by low-speed
centrifugation (1,000 g, 5 minutes) and concentrated by
using centrifugal filters (Centricon Plus-70®  Millipore,
Billerica, MA). Virus was adjusted to a final concentration
of 128 chicken erythrocyte hemagglutination units per 50
μl in PBS containing 3% bovine serum albumin (BSA).
Glycan microarray binding analysis was performed as pre-
viously described [20,31]. Briefly, virus bound on the
arrays was detected with ferret anti-H7 antibody or con-
trol serum in PBS-BSA followed by biotinylated anti-ferret
IgG, respectively. Bound antibody complexes were
detected with Alexa Flour 488 labeled streptavidin. Mock-
infected allantoic fluid was used as negative control (not
shown).
Growth curve in HAE cells
Growth curves in HAE cells were performed as described
previously [19]. Briefly, duplicate HAE cultures growing in
12 mm-diameter inserts were inoculated with each virus
via the apical side at an MOI of 0.2. After incubation at
35°C for 1 h, the inoculum was removed, the cells were
washed five times with 200 μl of growth medium and sub-
sequently incubated at 37°C in 5% CO2. At different time
points post-inoculation, 200 μl of growth medium was
added to each culture to harvest, allowed to mix for 10
min at 37°C and an equal volume of culture medium con-
taining progeny viruses was harvested, aliquoted, and
stored at -80°C. Virus TCID50 titers were determined in
MDCK cells.
Double immunostaining to determine infection of different 
HAE cell types
Infected HAE cultures were thoroughly washed with
growth medium, fixed with 4% paraformaldehyde, and
then permeabilized with 0.2% Triton X-100. Potential
endogenous peroxidase activity was eliminated with 1%
H2O2-methanol. After being blocked with 1% BSA-PBS,
the cells were incubated with a specific monoclonal anti-
body against β-tubulin (Sigma, St. Louis, MO), the cellu-
lar marker of ciliated cells, followed by incubation with
peroxidase-conjugated goat anti-mouse immunoglobulin
G (IgG; Sigma, St. Louis, MO). The cilia were visualized by
developing the cells in Vector SG substrate (Vector Labo-
ratories, Inc., Burlingame, CA). After being washed with
PBS and blocked with 1% BSA in PBS, the virus-infected
cells were incubated with chicken antisera against avian
influenza viruses prepared in our laboratory (with HA
inhibition titers of >320), followed by incubation with
peroxidase-conjugated goat anti-chicken IgG (Kirkegaard
& Perry Laboratories, Gaithersburg, MD). The viral anti-
gen was visualized by incubating the cells in AEC solution
(Sigma, St. Louis, MO). The cultures were mounted and
en face to be photographed for representative images. To
determine the number of infected cells and the tropisms
of the viruses, the stained cultures were observed at 400×
magnification.
Replication and transmission studies in birds, mice, and 
ferrets
Four to six-week old Japanese quail (Coturnix coturnix,
University of Maryland, College Park, Central Animal
Research Facility) and three to four-week White Leghorn
chickens (Charles River Laboratories, Wilmington, MA)
were used. Groups of three birds were inoculated via the
oral, intraocular, intranasal, and intratracheal routes with
5 × 106 EID50 of RGMal/01 per ml. A volume of 0.6 ml or
1.0 ml of virus inoculum was used for quail and chickens,
respectively. Three quail (or chickens) were introduced at
1 day post-infection (dpi) into the cage where the infected
quail (or chickens) were kept. Water and food bowls as
well as cage liners were changed in order to prevent trans-
mission of virus via contaminated feed or water. Tracheal
and cloacal swabs were collected at 1, 3, 5, 7, 9, 11 dpi andVirology Journal 2009, 6:126 http://www.virologyj.com/content/6/1/126
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stored in glass vials in 1 ml of freezing medium [50% glyc-
erol in phosphate saline buffer (PBS) – containing antibi-
otics] and titrated in 10-day embryonated chicken eggs by
the method of Reed and Muench [37]. Birds were
observed and scored daily for clinical signs of illness.
BALB/c mice (4–5 week old females, Charles River) were
anesthetized and infected intranasally (i.n.) with the
RGMal/01 virus at a dose of 50, 500, 5.0 × 103, 5.0 × 104,
5 × 105 TCID50/50 μl. One group of four mice was moni-
tored and weighed daily for 14 days, whereas a second
group of three mice was sacrificed at 3 dpi, brains and
lungs were collected and homogenated to titrate the virus
by TCID50 in MDCK cells.
Female Fitch ferrets, 3 to 6 months old (Triple F farms,
Sayre, PA), were used to test virus replication and trans-
mission. Prior to infection, ferrets were monitored for 3–
5 days to measure body weight and establish baseline
body temperatures. Temperature readings were recorded
daily through a transponder (Bio Medic data systems, Sea-
ford, DE) implanted subcutaneously in each ferret. Blood
was collected at 3 days before infection, and serum was
tested for antibodies against RGMal/01 virus using the
hemagglutination inhibition (HI) assay. Ferrets with HI
titers at or lower than 10 were considered "influenza A-
free" and were used in the study. Ferrets were housed in
wire cages placed inside Hepa-filter isolators. Each ferret
group housed in a single isolator unit consisted of three
ferrets: one infected, one direct contact and one aerosol
contact, as described previously [26,31]. Three groups (9
ferrets) were used in this study. In each group, one ferret
was lightly anesthetized with ketamine (20 mg/kg) and
xylazine (1 mg/kg) via intramuscular injection and inocu-
lated i.n. with 5 × 105TCID50 of RGMal/01 in PBS, 250 μl
per nostril. Twenty-four hours later, two naïve ferrets were
introduced. One (direct contact) was introduced directly
into the cage with the infected ferret while the other (aer-
osol contact) was placed in a cage separated from the
infected ferrets by a wire mesh (1 mm openings). The wire
mesh prevented physical contact between the aerosol and
the infected and direct contacts, allowing only air to be
shared between the ferrets. All materials inside the cage of
inoculated ferrets were removed and replaced before
introducing the direct contact to preclude fomite trans-
mission. Temperatures and body weight readings were
taken daily. To monitor viral shedding, nasal washes were
collected daily for up to 14 days. Briefly, ferrets were anes-
thetized as described above, and 1 ml of PBS was used to
induce sneezing. Nasal washes were collected into petri
dishes and brought to a total volume of 1 ml with PBS.
Nasal washes were immediately tested for virus using the
Flu DETECT™ Antigen Capture Test Strip (Synbiotics
Corp., San Diego, CA) and additional aliquots were stored
at -80°C before performing TCID50 assays. Two weeks
after infection, blood was collected and seroconversion
was monitored by determining HI antibody titers.
To study the kinetics of virus replication and tissue tro-
pism in ferrets, 3 ferrets were inoculated i.n. with 5 × 105
TCID50 of RGMal/01 as described above. At 8, 24, and 68
hours post-infection (hpi), each ferret was euthanized.
Nasal turbinates, lungs, kidneys, olfactory bulbs (OB),
brains, livers, spleens and intestines were harvested, and
samples were both fixed with buffered neutral formalin
for histological evaluation and stored at -80°C for virus
titration. For histopathology, paraffin-embedded sections
of 5 μm thicknesses were cut and stained with hematoxy-
lin and eosin (H&E) (Histoserv, Inc., Germantown, MD).
Representative microscopic photos were taken with SPOT
ADVANCED software (Version 4.0.8, Diagnostic Instru-
ments, Inc., Sterling Heights, MI). The virus titer for each
organ was determined by the method described by Reed
and Muench and was expressed as log10  numbers of
TCID50 per ml of 10% (w/v) tissue homogenate.
Animal experiments were carried out under BSL-2 (birds
and mice study) or BSL-2+ (ferret study) conditions and
conducted under guidelines approved by the IACUC of
the University of Maryland.
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